Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 4;188(18):4924-4935.e23.
doi: 10.1016/j.cell.2025.06.026. Epub 2025 Jul 14.

An alternate receptor for adeno-associated viruses

Affiliations
Free article

An alternate receptor for adeno-associated viruses

Bijay P Dhungel et al. Cell. .
Free article

Abstract

Systemic gene therapy using adeno-associated virus (AAV) vectors is approved for the treatment of several genetic disorders, but challenges and toxicities associated with high vector doses remain. We report an alternate receptor for AAV (AAVR2, carboxypeptidase D [CPD]), which is distinct from the multi-serotype AAV receptor (AAVR). AAVR2 enables the transduction of clade E AAVs, including AAV8, and determines an exclusive AAVR-independent transduction pathway for AAV11 and AAV12. We characterized direct binding between the AAV8 capsid and AAVR2 by cryo-electron microscopy (cryo-EM) and identified contact residues. We observed that AAV8 directly binds to the carboxypeptidase-like domain 1 of AAVR2 via its variable region VIII and demonstrated that AAV capsids that lack AAVR2 binding can be bioengineered to engage with AAVR2. Finally, we overexpressed a minimal functional AAVR2 to enhance AAV transduction in vivo. Our study provides insights into AAV biology and clinically deployable solutions to reduce dose-related toxicities associated with AAV vectors.

Keywords: AAVR2; CRISPRa; KIAA0319L; capsid; carboxypeptidase D; gene transfer; genetic therapy; genome-wide CRISPR screen; molecular therapy; serotypes.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests B.P.D., C.G.B., and J.E.J.R. are inventors on a patent (PCT/AU2024/051111) related to this work and are co-founders of AAVec Bio Pty Ltd.

LinkOut - more resources